U S Stem Cell Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the fourth quarter 2022, U S Stem Cell Inc 's inventory turnover ratio sequentially decreased to 31.94 in the fourth quarter 2022, otherwise the ratio remained above the average, as USRM's markets remain strong.U S Stem Cell Inc 's average inventory processing period in the Dec 31 2022 quarter, has increased to 11 days, from 8 days, in the Sep 30 2022 quarter.

Within Healthcare sector 10 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 115 in the third quarter 2022, to 175.

USRM Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is U S Stem Cell Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

USRM Inventory Turnover Ratio	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter
Y / Y Inventory Growth	149.36 %	-63.85 %	-85.06 %	-83.23 %	-92.75 %
Y / Y Cost of Sales Growth	-42.99 %	-62.93 %	-54.32 %	-52.74 %	-18.31 %
Inventory Turnover Ratio (TTM)	31.94	46.01	40.14	23.01	19.7
USRM's Total Ranking	# 175	# 115	# 130	# 115	# 125
Average inventory processing period	11	8	9	16	19
Seq. Inventory Growth	39.6 %	0.14 %	18.21 %	50.89 %	-79.76 %
Seq. Cost of Sales Growth	-6.52 %	-15.74 %	-14.83 %	-15.03 %	-39.21 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Laboratories Industry	# 2
Healthcare Sector	# 11
Overall Market	# 175

Inventory Turnover Ratio Statistics
High	Average	Low
46.01	24.85	0.02
(Sep 30 2022)		(Dec 31 2012)

USRM Company Profile >> Back to USRM Efficiency Comparisons >> Compare USRM Inventory Turnover Ratio to its Competitors

Financial Statements
U S Stem Cell Inc 's Inventories	$ 0 Millions	Visit USRM's Balance sheet
U S Stem Cell Inc 's Cost of Revenues TTM	$ 0 Millions	Visit USRM's Income Statement
What are USRM's Sales?		Visit USRM's Sales by Segment

Other Inventory Turnover Ratios
U S Stem Cell Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Laboratories Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
USRM's Inventory Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for USRM's Competitors
Inventory Turnover Ratio for USRM's Suppliers
Inventory Turnover Ratio for USRM's Customers

You may also want to know
USRM's Sales Growth Rates	USRM's Pe Price to earnings ratio	USRM's Receivables Turnover Ratio	USRM's Stock Quote
USRM's Net Income Growth Rates	USRM's Ps Price to Sales ratio	USRM's Sales per Employee	USRM's Asset Turnover Ratio
USRM's Net Margin	USRM's Pb Price to Book ratio	USRM's Financial Strength Ratios	USRM's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Dec 31 2022	Inventories at quarter ending Dec 31 2022
Meihua International Medical Technologies Co Ltd	66.47	$ 65.248 Millions	$ 1 Millions
Healthcare Services Group Inc	64.79	$ 1,493.956 Millions	$ 23 Millions
1life Healthcare Inc	62.39	$ 441.499 Millions	$ 7 Millions
Uphealth Inc	40.86	$ 98.358 Millions	$ 2 Millions
Quest Diagnostics Inc	33.99	$ 6,450.000 Millions	$ 190 Millions
Scienture Holdings Inc	33.52	$ 5.000 Millions	$ 0 Millions
U s Stem Cell Inc	31.94	$ 0.024 Millions	$ 0 Millions
The Oncology Institute Inc	25.95	$ 231.140 Millions	$ 9 Millions
Rennova Health Inc	25.75	$ 6.768 Millions	$ 0 Millions
Intelgenx Technologies Corp	23.59	$ 1.858 Millions	$ 0 Millions
Labcorp Holdings Inc	23.12	$ 10,491.700 Millions	$ 454 Millions
Adapthealth Corp	22.42	$ 2,553.169 Millions	$ 114 Millions
Harmony Biosciences Holdings inc	19.64	$ 83.481 Millions	$ 4 Millions
Etao International Co Ltd	19.63	$ 39.060 Millions	$ 2 Millions
Vaso Corporation	19.42	$ 31.537 Millions	$ 2 Millions
Fresh2 Group Ltd	17.93	$ 0.538 Millions	$ 0 Millions
Viemed Healthcare Inc	17.89	$ 54.152 Millions	$ 3 Millions
Vanda Pharmaceuticals Inc	17.44	$ 24.282 Millions	$ 1 Millions
Aspira Women s Health inc	15.82	$ 3.861 Millions	$ 0 Millions
Biocept Inc	14.00	$ 28.440 Millions	$ 2 Millions
23andme Holding Co	13.84	$ 166.100 Millions	$ 12 Millions
Natera Inc	13.74	$ 451.016 Millions	$ 33 Millions
Rvl Pharmaceuticals Plc	13.65	$ 9.456 Millions	$ 1 Millions
Option Care Health Inc	13.54	$ 3,077.817 Millions	$ 227 Millions
Eton Pharmaceuticals Inc	13.34	$ 6.933 Millions	$ 1 Millions
Rockwell Medical inc	12.25	$ 65.973 Millions	$ 5 Millions
Teladoc Health Inc	12.07	$ 743.987 Millions	$ 62 Millions
Prophase Labs Inc	11.50	$ 51.993 Millions	$ 5 Millions
Myriad Genetics Inc	11.43	$ 202.000 Millions	$ 18 Millions
Sotera Health Company	11.19	$ 446.683 Millions	$ 40 Millions

Date modified: 2026-06-22T14:32:27+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.